Talk:Latent tuberculosis

message: I question the neutrality of this section: "In particular, US recommendation is that prior BCG vaccination be ignored in the interpretation of tuberculin skin tests, which means that many more people (particularly foreign nationals who will almost all have had BCG) who have nothing wrong with them will end up having unnecessary treatment with potentially toxic drugs. There are two reasons for this: (1) people who have previously had BCG (even may years ago) may still have a false positive Mantoux test, and (2) serial testing with tuberculin skin tests boosts the immunological response in those people who have previously had BCG, so these people will falsely appear to be tuberculin converters." It fails to address the fact that BCG is not fully protective, less protective in adults than pediatric, and in areas where QFT is not widely available or cost-effective, the concern over missing an LTBI is great enough that the benefits are considered to outweigh the risks in generally low-prevalence areas such as the USA.
: I concur. The article, as written, seems a bit biased. How does the following sound:
:: Given that the US recommendation is that prior BCG vaccination be ignored in the interpretation of tuberculin skin tests, false positives are possible as a result of: (1) people who have previously had BCG (even may years ago) may still have a false positive Mantoux test, and (2) serial testing with tuberculin skin tests boosts the immunological response in those people who have previously had BCG, so these people will falsely appear to be tuberculin converters. This may lead to treating more people than necessary, with the possible risk of those patients suffering adverse drug reactions.  However, as Bacille_Calmette-Guérin vaccine is not 100% effective, and is less protective in adults than pediatric patients, not treating these patients could lead to a possible infection.  The current US policy seems to a reflect a desire to err on the side of safety (of the general public). 
: PS. Please sign all your contributions in the future.  Cheers, --bfigura (talk) 04:04, 16 August 2007 (UTC)
replies: text: Change implemented, and section detagged. bfigura (talk) 17:30, 16 August 2007 (UTC)
thread_title: US guidelines for BCG

message: This meta-analysis compares regimens and advocates rifamycin-containing treatment protocols: doi:10.7326/M14-1019 JFW | T@lk 09:33, 28 August 2014 (UTC)
thread_title:  Comparison of regimens 

message: Hello fellow Wikipedians,
I have just added archive links to  on Latent tuberculosis. Please take a moment to review my edit. If necessary, add  after the link to keep me from modifying it. Alternatively, you can add  to keep me off the page altogether. I made the following changes:
*Added archive https://web.archive.org/20131021150709/http://health.nytimes.com:80/health/guides/test/ppd-skin-test to http://health.nytimes.com/health/guides/test/ppd-skin-test/
When you have finished reviewing my changes, please set the checked parameter below to true to let others know.
Cheers.—cyberbot IITalk to my owner:Online 01:44, 15 January 2016 (UTC)
thread_title:  External links modified 

message: Review in Annals of Internal Medicine - doi:10.7326/M17-0609 JFW | T@lk 08:46, 1 August 2017 (UTC)
thread_title:  Treatment 

message: Epidemiology is given for active TB while the article is about latent  TB. Epidemiology of latent  TB is very different: from 20% to 90% people are infected depending on country. COM-03 (talk) 10:56, 3 February 2023 (UTC)
thread_title:  Epidemiology